Koyfin Home > Directory > Health Care > Iovance Biotherapeutics Inc > Total Debt / Equity

Iovance Biotherapeutics Inc Total Debt / Equity Chart (IOVA)

Iovance Biotherapeutics Inc annual/quarterly Total Debt / Equity from 2010 to 2020. Debt to equity is a measure of leverage in a company and expressed as a ratio of the total debt relative to book value of equity.
  • Iovance Biotherapeutics Inc Total Debt / Equity for the quarter ending September 09, 2020 was $2m a -151.04% decrease of -2m year over year
  • Iovance Biotherapeutics Inc Total Debt / Equity for the last 12 months ending September 09, 2020 was $2m a -151.04% decrease of -2m year over year
  • Iovance Biotherapeutics Inc Annual Total Debt / Equity for 2019 was $4m a 1,588.56% increase of 61m from 2018
  • Iovance Biotherapeutics Inc Annual Total Debt / Equity for 2012 was $-57m a 31.68% decrease of -18m from 2011
  • Iovance Biotherapeutics Inc Annual Total Debt / Equity for 2011 was $-39m
Other Ratios Metrics:
  • Iovance Biotherapeutics Inc Total Debt / Capital for the quarter ending March 03, 2010 was $3m
  • Iovance Biotherapeutics Inc Other Liabilities for the quarter ending March 03, 2014 was $0m
View Chart On Koyfin

Quarterly IOVA Total Debt / Equity Data

09/2020$2m
06/2020$1m
03/2020$4m
12/2019$4m
09/2019$4m
06/2019$3m
03/2019$2m
03/2013$-55m
12/2012$-57m
09/2012$-39m

Annual IOVA Total Debt / Equity Data

2019$4m
2012$-57m
2011$-39m